E-LIB Suche - Ergebnisse für: Laroni A

1

Personalizing ocrelizumab treatment in Multiple Sclerosis: ..:

Tazza, F. ; Lapucci, C. ; Cellerino, M....
Journal of the Neurological Sciences. 427 (2021) - p. 117501 , 2021

Link: https://doi.org/10.1016/..

2

Informing MS patients on treatment options: a consensus on ..:

on behalf of the RIReMS Group ; Tortorella, C. ; Solaro, C....
Neurological Sciences. 41 (2020) 8 - p. 2249-2253 , 2020

Link: https://doi.org/10.1007/..

3

Assessing upper limb function in multiple sclerosis using a..:

Carmisciano, L. ; Signori, A. ; Pardini, M....
European Journal of Neurology. 27 (2020) 12 - p. 2561-2567 , 2020

Link: https://doi.org/10.1111/..

4

Aggressive multiple sclerosis: a single‐centre, real‐world ..:

Boffa, G. ; Lapucci, C. ; Sbragia, E....
European Journal of Neurology. 27 (2020) 10 - p. 2047-2055 , 2020

Link: https://doi.org/10.1111/..

5

Factors interfering with parenthood decision-making in an I..:

Lavorgna, L. ; Esposito, S. ; Lanzillo, R....
Journal of Neurology. 266 (2019) 3 - p. 707-716 , 2019

Link: https://doi.org/10.1007/..

6

Serum sickness (Like Reaction) in a patient treated with al..:

Lapucci, C ; Gualandi, F ; Mikulska, M...
Multiple Sclerosis and Related Disorders. 26 (2018) - p. 52-54 , 2018

Link: https://doi.org/10.1016/..

7

Early switch to fingolimod may decrease the risk of disease..:

Laroni, A ; Brogi, D ; Milesi, V...
Multiple Sclerosis Journal. 19 (2012) 9 - p. 1236-1237 , 2012

Link: https://doi.org/10.1177/..

8

Urinary JCV-DNA Testing during Natalizumab Treatment May In..:

Laroni, A. ; Giacomazzi, C. G. ; Grimaldi, L....
Journal of Neuroimmune Pharmacology. 7 (2012) 3 - p. 665-672 , 2012

Link: https://doi.org/10.1007/..

9

A case of thyroiditis during natalizumab therapy for multip..:

Oddo, S. ; Laroni, A. ; Uccelli, A..
Journal of Endocrinological Investigation. 34 (2011) 5 - p. 408-409 , 2011

Link: https://doi.org/10.1007/..

10

Association of melanoma and natalizumab therapy in the Ital..:

Laroni, A. ; Bedognetti, M. ; Uccelli, A...
Neurological Sciences. 32 (2010) 1 - p. 181-182 , 2010

Link: https://doi.org/10.1007/..

11

Three years of experience: the Italian registry and safety ..:

Mancardi, G. L. ; Tedeschi, G. ; Amato, M. P....
Neurological Sciences. 31 (2010) S3 - p. 295-297 , 2010

Link: https://doi.org/10.1007/..

12

Multiple sclerosis and autoimmune diseases: Epidemiology an..:

Laroni, A. ; Calabrese, M. ; Perini, P....
Journal of Neurology. 253 (2006) 5 - p. 636-639 , 2006

Link: https://doi.org/10.1007/..

13

Relapsing meningitis and limbic encephalitis in anti-AQP4-A..:

Novi, Giovanni ; Sbragia, Elvira ; Benedetti, Luana...
Multiple Sclerosis Journal. , 2024

Link: https://doi.org/10.1177/..

14

Central serous chorioretinopathy in multiple sclerosis and ..:

Sirito, Tommaso ; Cassottana, Paola ; Iester, Michele.
Neurological Sciences. , 2024

Link: https://doi.org/10.1007/..

15

SARS-CoV-2 vaccination and multiple sclerosis: a large mult..:

Di Filippo, Massimiliano ; Ferraro, Diana ; Ragonese, Paolo...
Journal of Neurology. 271 (2023) 1 - p. 24-31 , 2023

Link: https://doi.org/10.1007/..